Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001753926-25-001260·Cellectar Biosciences, Inc.
Schedule 13G ownership disclosure
CELLECTAR BIOSCIENCES INC
Common Stock, par value $0.00001 per share · CUSIP: 15117F880
Event date: 2025-07-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Hexstone Capital LLC
Shares: 150,000.00 · Class: 5.6%
- Brendan O'Neil
Shares: 150,000.00 · Class: 5.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-25-001260
- Form type
- SCHEDULE 13G
- Filer
- Cellectar Biosciences, Inc.
- CIK
- CIK 1279704
- Filed
- Aug 08, 2025
- Reporting period
- Jul 02, 2025
- Description
- Schedule 13G beneficial ownership